| Lucia Mazza, AA | |
|
3501 Johnson St, Hollywood, FL 33021-5421 | |
| (954) 987-2000 | |
| Not Available |
| Full Name | Lucia Mazza |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology Assistant |
| Experience | 9 Years |
| Location | 3501 Johnson St, Hollywood, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083082291 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | (* (Not Available)) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cleveland Clinic Hospital | Weston, FL | Hospital |
| Memorial Regional Hospital | Hollywood, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sheridan Healthcorp Inc | 3173429693 | 866 |
| Cleveland Clinic Florida A Nonprofit Corporation | 7911807128 | 618 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today announced the expansion of its Human Genetic Therapies pipeline through the exclusive license, in markets outside of North America, for the activin receptor type IIB class of molecules being developed by Acceleron Pharma Inc., a private biotechnology company based in Cambridge, Massachusetts.
BioScale, Inc. a life science company that develops ultrasensitive protein analysis technology, presented findings of recently completed research studies on phospho-protein analysis of the activation state of the MAP kinase pathway at the 103rd Annual Meeting of the American Association for Cancer Research (AACR), held at McCormick Place in Chicago, Illinois, March 31 - April 4, 2012.
At the 64th ASMS Conference, Bruker announces the launch of the new rapifleX™ MALDI PharmaPulse™ (MPP) solution. It is the latest addition to Bruker's portfolio of innovative products designed to assist pharmaceutical, biotech and CRO customers to accelerate drug discovery, and rapifleX MPP can dramatically lower the cost of ultra-high throughput screening (uHTS) with further improved results.
Philips Lighting, a global leader in lighting, today announced its third generation Philips HealWell lighting system that is specifically developed to support sleep and improve patients' and staff's experience, comfort and satisfaction in healthcare facilities.
A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiation therapy, finds a new long-term clinical trial report.
› Verified 7 days ago
| Entity Name | Sheridan Healthcorp Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629781711 PECOS PAC ID: 3173429693 Enrollment ID: O20031208000355 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today announced the expansion of its Human Genetic Therapies pipeline through the exclusive license, in markets outside of North America, for the activin receptor type IIB class of molecules being developed by Acceleron Pharma Inc., a private biotechnology company based in Cambridge, Massachusetts.
BioScale, Inc. a life science company that develops ultrasensitive protein analysis technology, presented findings of recently completed research studies on phospho-protein analysis of the activation state of the MAP kinase pathway at the 103rd Annual Meeting of the American Association for Cancer Research (AACR), held at McCormick Place in Chicago, Illinois, March 31 - April 4, 2012.
At the 64th ASMS Conference, Bruker announces the launch of the new rapifleX™ MALDI PharmaPulse™ (MPP) solution. It is the latest addition to Bruker's portfolio of innovative products designed to assist pharmaceutical, biotech and CRO customers to accelerate drug discovery, and rapifleX MPP can dramatically lower the cost of ultra-high throughput screening (uHTS) with further improved results.
Philips Lighting, a global leader in lighting, today announced its third generation Philips HealWell lighting system that is specifically developed to support sleep and improve patients' and staff's experience, comfort and satisfaction in healthcare facilities.
A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiation therapy, finds a new long-term clinical trial report.
› Verified 7 days ago
| Entity Name | Drs. Ellis, Rojas, Ross And Debs, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255313169 PECOS PAC ID: 4587563408 Enrollment ID: O20040108000602 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today announced the expansion of its Human Genetic Therapies pipeline through the exclusive license, in markets outside of North America, for the activin receptor type IIB class of molecules being developed by Acceleron Pharma Inc., a private biotechnology company based in Cambridge, Massachusetts.
BioScale, Inc. a life science company that develops ultrasensitive protein analysis technology, presented findings of recently completed research studies on phospho-protein analysis of the activation state of the MAP kinase pathway at the 103rd Annual Meeting of the American Association for Cancer Research (AACR), held at McCormick Place in Chicago, Illinois, March 31 - April 4, 2012.
At the 64th ASMS Conference, Bruker announces the launch of the new rapifleX™ MALDI PharmaPulse™ (MPP) solution. It is the latest addition to Bruker's portfolio of innovative products designed to assist pharmaceutical, biotech and CRO customers to accelerate drug discovery, and rapifleX MPP can dramatically lower the cost of ultra-high throughput screening (uHTS) with further improved results.
Philips Lighting, a global leader in lighting, today announced its third generation Philips HealWell lighting system that is specifically developed to support sleep and improve patients' and staff's experience, comfort and satisfaction in healthcare facilities.
A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiation therapy, finds a new long-term clinical trial report.
› Verified 7 days ago
| Entity Name | Cleveland Clinic Florida A Nonprofit Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215989298 PECOS PAC ID: 7911807128 Enrollment ID: O20040113000394 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today announced the expansion of its Human Genetic Therapies pipeline through the exclusive license, in markets outside of North America, for the activin receptor type IIB class of molecules being developed by Acceleron Pharma Inc., a private biotechnology company based in Cambridge, Massachusetts.
BioScale, Inc. a life science company that develops ultrasensitive protein analysis technology, presented findings of recently completed research studies on phospho-protein analysis of the activation state of the MAP kinase pathway at the 103rd Annual Meeting of the American Association for Cancer Research (AACR), held at McCormick Place in Chicago, Illinois, March 31 - April 4, 2012.
At the 64th ASMS Conference, Bruker announces the launch of the new rapifleX™ MALDI PharmaPulse™ (MPP) solution. It is the latest addition to Bruker's portfolio of innovative products designed to assist pharmaceutical, biotech and CRO customers to accelerate drug discovery, and rapifleX MPP can dramatically lower the cost of ultra-high throughput screening (uHTS) with further improved results.
Philips Lighting, a global leader in lighting, today announced its third generation Philips HealWell lighting system that is specifically developed to support sleep and improve patients' and staff's experience, comfort and satisfaction in healthcare facilities.
A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiation therapy, finds a new long-term clinical trial report.
› Verified 7 days ago
| Entity Name | Anesco North Broward Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699763862 PECOS PAC ID: 3173436094 Enrollment ID: O20040225000118 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today announced the expansion of its Human Genetic Therapies pipeline through the exclusive license, in markets outside of North America, for the activin receptor type IIB class of molecules being developed by Acceleron Pharma Inc., a private biotechnology company based in Cambridge, Massachusetts.
BioScale, Inc. a life science company that develops ultrasensitive protein analysis technology, presented findings of recently completed research studies on phospho-protein analysis of the activation state of the MAP kinase pathway at the 103rd Annual Meeting of the American Association for Cancer Research (AACR), held at McCormick Place in Chicago, Illinois, March 31 - April 4, 2012.
At the 64th ASMS Conference, Bruker announces the launch of the new rapifleX™ MALDI PharmaPulse™ (MPP) solution. It is the latest addition to Bruker's portfolio of innovative products designed to assist pharmaceutical, biotech and CRO customers to accelerate drug discovery, and rapifleX MPP can dramatically lower the cost of ultra-high throughput screening (uHTS) with further improved results.
Philips Lighting, a global leader in lighting, today announced its third generation Philips HealWell lighting system that is specifically developed to support sleep and improve patients' and staff's experience, comfort and satisfaction in healthcare facilities.
A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiation therapy, finds a new long-term clinical trial report.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lucia Mazza, AA 713 Se 6th Ct, Fort Lauderdale, FL 33301-3113 Ph: (813) 389-4373 | Lucia Mazza, AA 3501 Johnson St, Hollywood, FL 33021-5421 Ph: (954) 987-2000 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today announced the expansion of its Human Genetic Therapies pipeline through the exclusive license, in markets outside of North America, for the activin receptor type IIB class of molecules being developed by Acceleron Pharma Inc., a private biotechnology company based in Cambridge, Massachusetts.
BioScale, Inc. a life science company that develops ultrasensitive protein analysis technology, presented findings of recently completed research studies on phospho-protein analysis of the activation state of the MAP kinase pathway at the 103rd Annual Meeting of the American Association for Cancer Research (AACR), held at McCormick Place in Chicago, Illinois, March 31 - April 4, 2012.
At the 64th ASMS Conference, Bruker announces the launch of the new rapifleX™ MALDI PharmaPulse™ (MPP) solution. It is the latest addition to Bruker's portfolio of innovative products designed to assist pharmaceutical, biotech and CRO customers to accelerate drug discovery, and rapifleX MPP can dramatically lower the cost of ultra-high throughput screening (uHTS) with further improved results.
Philips Lighting, a global leader in lighting, today announced its third generation Philips HealWell lighting system that is specifically developed to support sleep and improve patients' and staff's experience, comfort and satisfaction in healthcare facilities.
A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiation therapy, finds a new long-term clinical trial report.
› Verified 7 days ago
Nicole Leslie Jones, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 3600 Washington St, Hollywood, FL 33021 Phone: 954-966-4500 | |
Julia Smith, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1005 Joe Dimaggio Dr, Hollywood, FL 33021 Phone: 954-265-5324 | |
Nga Le, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 3600 Washington St, Hollywood, FL 33021 Phone: 855-367-3650 | |
Sara Patricia Brusco, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 3501 Johnson Street, Hollywood, FL 33021 Phone: 239-332-5344 Fax: 239-332-7246 | |
Mr. Adam M Fernandez Sr., CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 3600 Washington St, Hollywood, FL 33021 Phone: 954-985-6310 | |
Ms. Jana Angel, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 3501 Johnson St, Hollywood, FL 33021 Phone: 954-987-5662 |